Wylie W Vale, Jr

This inventor holds 100 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Corticotropin-Releasing Factor (CPC class 530324). Top assignees: The Salk Institute, Research Development Foundation, University of Reading. Active years: 1978-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wylie W Vale, Jr. Retrieved from https://idiyas.com/inventor/wylie-w-vale-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 100 (Patent Applications = 5)

% Patents Active = 92.0

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 3.3

ph-index = 21

Forward Citations = 1,619(Granted Patents)

Forward Citations (Not Self Cited) = 1,490(Dec 10, 2025)

Inventors with similar research interests:

Location History:

La Jolla, CA (US) (1978 - 2013)
Carson City, NV (US) (2014)
(2016 - 2017)

Company Filing History:

Research Development Foundation

patents

3 out of 10

University of Reading

patents

4. 1 out of 122

Scripps Clinic and Research Foundation

patents

5. 1 out of 1,208

Scripps Research Institute

patents

6. 1 out of 16,035

University of California

patents

where one patent can have more than one assignee

Years Active: 1978-2017

Loading Chart...

Areas of Expertise:

Urocortin

Corticotropin-Releasing Factor

CRF Receptors

Activin Receptors

G-Protein Coupled Receptors

CRF Antagonists

Recombinant Proteins

Peptides

Binding Proteins

Transgenic Mice

100 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9572866 - Urocortin 2 analogs and uses thereof (2017-02-21),

2. 9388229 - Urocortin-III and uses thereof (2016-07-12),

3. 8669092 - Urocortin-III and uses thereof (2014-03-11),

4. 8445425 - Urocortin-III and uses thereof (2013-05-21),

5. 8084413 - Urocortin-III and uses thereof (2011-12-27),

6. 8044025 - Urocortin proteins and uses thereof (2011-10-25),

7. 7893213 - Antibodies to activin receptor (2011-02-22),

8. 7869958 - Structure-based modulators of B1 G-protein coupled receptors (2011-01-11),

9. 7851588 - CRFR1 selective ligands (2010-12-14),

10. 7459427 - Urocortin-III and uses thereof (2008-12-02),

11. 7358225 - Cloning and recombinant production of CRF receptor(s) (2008-04-15),

12. 6953838 - Urocortin-III and uses thereof (2005-10-11),

13. 6838274 - Urocortin proteins and uses thereof (2005-01-04),

14. 6835544 - Methods of screening for compounds that bind to activin receptor (2004-12-28),

15. 6812210 - Urocortin-III and uses thereof (2004-11-02),

Title: The Innovative Journey of Wylie W. Vale, Jr.

Introduction: Wylie W. Vale, Jr. is a renowned inventor based in La Jolla, California. His groundbreaking work in the field of inventions has significantly impacted various industries.

Latest Patents: Wylie W. Vale, Jr. holds several patents in the areas of biotechnology and medical devices, showcasing his continuous commitment to innovation and advancement in these fields.

Career Highlights: With a distinguished career spanning several decades, Wylie W. Vale, Jr. has been instrumental in developing cutting-edge technologies that have revolutionized the way we approach healthcare and biotechnology.

Collaborations: Throughout his career, Wylie W. Vale, Jr. has collaborated with leading researchers, scientists, and institutions to further his inventions and bring them to fruition, solidifying his reputation as a visionary inventor.

Conclusion: Wylie W. Vale, Jr.'s passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventions. His contributions continue to inspire future generations of inventors and shape the landscape of biotechnology and medical devices.

Profile summary based on public USPTO records.